Evidence map›Paper›PMID 39830612›Full record

ArticleJournal of clinical and translational science2025

Training T-shaped translational scientists.

Molly Wasko, Kathryn Allen Nearing, Stacey L Neves, Amy Carrillo, Julie Rainwater, Jennifer A Croker, Robert P Kimberly

Abstract read
In one paragraph

Article in Journal of clinical and translational science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Embracing complexity: An opportunity for developmental evaluation.Journal of clinical and translational science · 2026
    Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Molly WaskoCenter for Clinical and Translational Science, University of Alabama at Birmingham, Birmingham, AL, USA.ORCID https://orcid.org/0000-0002-1982-1824
Kathryn Allen NearingDivision of Geriatric Medicine, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Stacey L NevesSchool of Medicine, Office of Research, University of California Davis, Sacramento, CA, USA.
Amy CarrilloSchool of Medicine, Office of Research, University of California Davis, Sacramento, CA, USA.
Julie RainwaterSchool of Medicine, Office of Research, University of California Davis, Sacramento, CA, USA.
Jennifer A CrokerCenter for Clinical and Translational Science, University of Alabama at Birmingham, Birmingham, AL, USA.ORCID https://orcid.org/0000-0002-6292-4132
Robert P KimberlyCenter for Clinical and Translational Science, University of Alabama at Birmingham, Birmingham, AL, USA.ORCID https://orcid.org/0000-0002-5330-3086

Funding

The Institute for Translational MedicineUL1TR002389 · NCATS · UNIVERSITY OF CHICAGO · PI Joshua J Jacobs, DAVID O MELTZER · 2017 to 2026
$71.6M
NCATS NIH HHS UL1 TR002389
6 · The paper itself

Abstract

To evaluate the design of I-Corps@NCATS as a translational scientist training program, we mapped specific elements of the program's content and pedagogy to the characteristics of a translational scientist, as first defined by Gilliland et al. []: systems thinker, process innovator, boundary spanner, team player, and skilled communicator. Using a mixed-methods evaluation, we examined how the I-Corps@NCATS training program, delivered across twenty-two Clinical and Translational Science Award Hubs, impacted the development of these key translational scientist characteristics. Methods: We developed survey items to assess the characteristics of systems thinker, process innovator, boundary spanner, team player, and skilled communicator. Data were collected from a national sample of 281 participants in the I-Corps@NCATS program. Using post-then-retrospective-pre survey items, participants self-reported their ability to perform skills associated with each of the translational scientist characteristics. Additionally, two open-ended survey questions explored how the program shifted participants' translational orientation, generating 211 comments. These comments were coded through a team-based, iterative process. Results: Respondents reported the greatest increases in self-assessed abilities related to systems thinking and skilled communication. Participants indicated the highest levels of abilities related to team player and boundary crosser. From the coding of open-ended comments, we identified two additional characteristics of translational scientists: intellectual humility and cognitive flexibility. Conclusions: Participation in I-Corps@NCATS accelerates translational science in two ways: 1) by teaching the process of scientific translation from research ideas to real-world solutions, and 2) by encouraging growth in the mindset and characteristics of a translational scientist.

Indexed as

customer discoveryI-CorpsTranslational scientistT-shaped scientistworkforce development

Identifiers

PMID39830612
PMCPMC11736293

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.